Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CSPG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SETD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA4F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM99 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MUM1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDPCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZADH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APBA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLCO1B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643201 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on